VASCERN COVID-19 Recommendations

 

With the current global spread of the novel coronavirus SARS Cov-2, causing COVID-19, the experts from the Rare Disease Working Groups of VASCERN have prepared the following consensus statements for patients with rare vascular diseases. These statements will be updated as necessary.

 

Hereditary Haemorrhgic Telangiectasia (HHT)

 

Heritable Thoracic Aortic Diseases (HTAD)

 

This statement can equally be found in:

Dutch: VASCERN HTAD verklaring over Covid 19

French: Déclaration du groupe de travail VASCERN sur les maladies aortiques thoraciques héréditaires (HTAD) sur COVID-19

German: VASCERN Erklärung zu Covid 19

Maltese: Stqarrija mill-VASCERN HTAD WG dwar il-COVID-19

Spanish: Declaración de VASCERN HTAD sobre Covid 19

 

Vascular Ehlers-Danlos syndrome (vEDS)

 

 

Pediatric and Primary Lymphedema (PPL)

 

German translation available here

 

Vascular Anomalies (VASCA)

 

This statement can equally be found in:

French: Information COVID-19 pour les patients porteurs d’ Anomalies Vasculaires et/ou Lymphatiques

Finnish: VASCERN Suonipoikkeavuuksien (VASCA) työryhmä – Tietoa koronaviruksesta (COVID-19) potilaille, joilla on vaikea suonipoikkeavuus

 

 

 

    Comments are closed